Gunhild Mari Mælandsmo
Remya Valsalakumari,
Abhilash D. Pandya,
Lina Prasmickaite,
Audun Sverre Myrset Kvalvaag,
Anne Grethe Myrann,
Karl Olof Andreas Åslund
et al.:
Preclinical Efficacy of Cabazitaxel Loaded Poly(2-alkyl cyanoacrylate) Nanoparticle Variants
Wanja Kildal,
Karolina Urszula Cyll,
Joakim Kalsnes,
Rakibul Islam,
Frida M. Julbø,
Manohar Pradhan
et al.:
Deep learning for automated scoring of immunohistochemically stained tumour tissue sections – Validation across tumour types based on patient outcomes
Heliyon 2024 DOI
Eivind Valen Egeland,
Kotryna Vasiliauskaite,
Eleni Skourti,
Geir Frode Øy,
Solveig Pettersen,
Abhilash D. Pandya
et al.:
The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy
Caroline Elisabeth Nunes-Xavier,
Maite Emaldi,
Janire Mingo,
Tove Ragnhild Øyjord,
Gunhild Mari Mælandsmo,
Øystein Fodstad
et al.:
The expression pattern of pyruvate dehydrogenase kinases predicts prognosis and correlates with immune exhaustion in clear cell renal cell carcinoma
Gisella Figlioli,
Amandine Billaud,
Thomas U. Ahearn,
Natalia N. Antonenkova,
Heiko Becher,
Matthias W. Beckmann
et al.:
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women
Salim Ghannoum,
Damiano Fantini,
Muhammad Zahoor,
Veronika Reiterer,
Santosh Phuyal,
Waldir Leoncio Netto
et al.:
A combined experimental-computational approach uncovers a role for the Golgi matrix protein Giantin in breast cancer progression
Solveig Pettersen,
Geir Frode Øy,
Eivind Valen Egeland,
Siri Juell,
Olav Engebråten,
Gunhild Mari Mælandsmo
et al.:
Breast cancer patient-derived explant cultures recapitulate in vivo drug responses
Lisa Gregusson Svartdal,
Mads Haugen,
Vesa Hongisto,
Miriam Ragle Aure,
Suvi-Katri Leivonen,
Vessela N. Kristensen
et al.:
High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer
Mads Haugen,
Hedda von der Lippe Gythfeldt,
Eivind Valen Egeland,
Lisa Svartdal Normann,
Abhilash D. Pandya,
Lise-Lotte Vedin
et al.:
Liver X receptors induce antiproliferative effects in basal-like breast cancer
Vigdis Nygaard,
Anne Hansen Ree,
Vegar Johansen Dagenborg,
Anne-Lise Børresen-Dale,
Bjørn von Gohren Edwin,
Åsmund Avdem Fretland
et al.:
A PRRX1 Signature Identifies TIM-3 and VISTA as Potential Immune Checkpoint Targets in a Subgroup of Microsatellite Stable Colorectal Cancer Liver Metastases
Erik Knutsen,
Saikat Das Sajib,
Tonje Fiskaa,
James Bradley Lorens,
Thorarinn Gudjonsson,
Gunhild Mari Mælandsmo
et al.:
Identification of a core EMT signature that separates basal-like breast cancers into partial- and post-EMT subtypes
Marta Sølvi Nyakas,
Karianne Giller Fleten,
Mads Haugland Haugen,
Nikolai Engedal,
Christina Sveen,
Inger Nina Farstad
et al.:
AXL inhibition improves BRAF-targeted treatment in melanoma
Caroline Elisabeth Nunes-Xavier,
Maite Emaldi,
Ingrid Jenny Guldvik,
Håkon Ramberg,
Kristin Austlid Tasken,
Gunhild Mari Mælandsmo
et al.:
Correlation of expression of Major Vault Protein with androgen receptor and immune checkpoint protein B7-H3, and with poor prognosis in prostate cancer
Anne Hansen Ree,
Gunhild Mari Mælandsmo,
Kjersti Flatmark,
Hege Elisabeth Giercksky Russnes,
Monica Gomez Casteneda,
Eline Aas
:
Cost-effectiveness of molecularly matched off-label therapies for end-stage cancer – the MetAction precision medicine study
Lisa Svartdal Normann,
Mads Haugland Haugen,
Miriam Ragle Aure,
Vessela N. Kristensen,
Gunhild Mari Mælandsmo,
Kristine Kleivi Sahlberg
:
miR-101-5p Acts as a Tumor Suppressor in HER2-Positive Breast Cancer Cells and Improves Targeted Therapy
Caroline Elisabeth Nunes-Xavier,
Janire Mingo,
Maite Emaldi,
Karine Flem-Karlsen,
Gunhild Mari Mælandsmo,
Øystein Fodstad
et al.:
Heterogeneous Expression and Subcellular Localization of Pyruvate Dehydrogenase Complex in Prostate Cancer
Frontiers in Oncology 2022 DOI
Elisa Fiorito,
Patrycja Maria Szybowska,
Ellen Margrethe Haugsten,
Michal Janusz Kostas,
Geir Frode Øy,
Antoni Wiedlocha
et al.:
Strategies to inhibit FGFR4 V550L-driven rhabdomyosarcoma
Margherita Ambrosini,
Marzia Del Re,
Paolo Manca,
Andrew Hendifar,
Alexander Drilon,
Guilherme Harada
et al.:
ALK Inhibitors in Patients with ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series
Sunniva Bjørklund,
Miriam Ragle Aure,
Jari Häkkinen,
Johan Vallon-Christersson,
Surendra Kumar,
Katrine Bull Evensen
et al.:
Subtype and cell type specific expression of lncRNAs provide insight into breast cancer
Marta Tellez Gabriel,
Xavier Tekpli,
Trine M. Reine,
Beate Hegge,
Stephanie Rose Nielsen,
Meng Chen
et al.:
Serglycin is Involved in TGF-β induced epithelial-mesenchymal transition and is highly expressed by immune cells in breast cancer tissue
Mateusz Adam Krzyscik,
Malgorzata Zakrzewska,
Vigdis Sørensen,
Geir Frode Øy,
Skjalg Bruheim,
Ellen Margrethe Haugsten
et al.:
Fibroblast growth factor 2 conjugated with monomethyl auristatin E inhibits tumor growth in a mouse model
Remya Valsalakumari,
Sunil Kumar Yadava,
Marzena Szwed,
Abhilash D. Pandya,
Gunhild Mari Mælandsmo,
Maria Lyngaas Torgersen
et al.:
Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells.
Abhilash D. Pandya,
Tore Geir Iversen,
Siver Andreas Moestue,
Maria Tunset Grinde,
Ýrr Asbjørg Mørch,
Sofie Snipstad
et al.:
Biodistribution of Poly(alkyl cyanoacrylate) Nanoparticles in Mice and Effect on Tumor Infiltration of Macrophages into a Patient-Derived Breast Cancer Xenograft
Sigurdur Karvelsson,
Qiong Wang,
Bylgja Hilmarsdòttir,
Arnar Sigurdsson,
Siver Andreas Moestue,
Gunhild Mari Mælandsmo
et al.:
Argininosuccinate lyase is a metabolic vulnerability in breast development and cancer
Sigurdur Karvelsson,
Arnar Sigurdsson,
Kotryna Seip,
Maria Tunset Grinde,
Qiong Wang,
Freyr Johanssson
et al.:
EMT-derived alterations in glutamine metabolism sensitize mesenchymal breast cells to mTOR inhibition
Caroline Elisabeth Nunes-Xavier,
Wanja Kildal,
Andreas Kleppe,
Håvard Emil Greger Danielsen,
Håkon Wæhre,
Roberto Llarena
et al.:
Immune checkpoint B7-H3 protein expression is associated with poor outcome and androgen receptor status in prostate cancer
Karianne Giller Fleten,
Jacobus Johannes Eksteen,
Brynjar Mauseth,
Ketil André Camilio,
Terje Vasskog,
Baldur Sveinbjørnsson
et al.:
Oncolytic peptides DTT-205 and DTT-304 induce complete regression and protective immune response in experimental murine colorectal cancer
Mads Haugland Haugen,
Ole Christian Lingjærde,
Ingrid Hedenfalk,
Øystein Garred,
Elin Borgen,
Niklas Loman
et al.:
Protein signature predicts response to neoadjuvant treatment with chemotherapy and bevacizumab in HER2-negative breast cancers
Henrik Aasrum Svendsen,
Torstein Ragnar Meling,
Vigdis Nygaard,
Stein Waagene,
Hege Elisabeth Giercksky Russnes,
Siri Juell
et al.:
Novel human melanoma brain metastasis models in athymic nude fox1nu mice: Site-specific metastasis patterns reflecting their clinical origin
Vegar Johansen Dagenborg,
Serena Marshall,
Krzysztof Grzyb,
Åsmund Avdem Fretland,
Marius Lund-Iversen,
Gunhild Mari Mælandsmo
et al.:
Low Concordance Between T-Cell Densities in Matched Primary Tumors and Liver Metastases in Microsatellite Stable Colorectal Cancer
Anna Barkovskaya,
Craig Goodwin,
Kotryna Seip,
Bylgja Hilmarsdòttir,
Solveig Pettersen,
Clint Stalnecker
et al.:
Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen
Tripti Tamhane,
Robin W. Njenga,
Roberta E. Burden,
Heiko Büth,
Gunhild Mari Mælandsmo,
Mads Haugland Haugen
et al.:
Trafficking of full-length and N-terminally truncated cathepsin B in human colorectal carcinoma cells
Applied Sciences 2021 DOI
Inga Hansine Rye,
Kanutte Huse,
Sarah Elisabet Josefsson,
Wanja Kildal,
Håvard Emil Greger Danielsen,
Ellen Schlichting
et al.:
Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression
Xing Yi Woo,
Jessica Giordano,
Anuj Srivastava,
Zi-Ming Zhao,
Michael W. Lloyd,
Roebi de Bruijn
et al.:
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts
Nature Genetics 2021 DOI
Lisa Gregusson Svartdal Normann,
Miriam Ragle Aure,
Suvi-Katri Leivonen,
Mads Haugland Haugen,
Vesa Hongisto,
Vessela N. Kristensen
et al.:
MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro
Abhilash D. Pandya,
Anders Øverbye,
Priyanka Saharia,
Vivek S. Gaware,
Håkon Høgset,
Már Masson
et al.:
Drug-Loaded Photosensitizer-Chitosan Nanoparticles for Combinatorial Chemo- and Photodynamic-Therapy of Cancer
Karine Flem-Karlsen,
Marta Sølvi Nyakas,
Inger Nina Farstad,
Erin McFadden,
Patrik Vernhoff,
Kari Dolven Jacobsen
et al.:
Soluble AXL as a marker of disease progression and survival in melanoma
Anne Hansen Ree,
Vigdis Nygaard,
Kjetil Boye Pedersen,
Daniel Heinrich,
Svein Dueland,
Inger Riise Bergheim
et al.:
Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer?the MetAction study
Erik Knutsen,
Seyed Mohammad Lellahi,
Miriam Ragle Aure,
Silje Nord,
Silje Fismen,
Kenneth Bowitz Larsen
et al.:
The expression of the long NEAT1_2 isoform is associated with human epidermal growth factor receptor 2-positive breast cancers
Jingjing Liu,
Wendy J. C. Prager van der Smissen,
Margriet J. Collee,
Manjeet K. Bolla,
Qin Wang,
Vessela N. Kristensen
et al.:
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk
Vegar Johansen Dagenborg,
Serena Elizabeth Marshall,
Krzysztof Grzyb,
Åsmund Avdem Fretland,
Marius Lund-Iversen,
Gunhild Mari Mælandsmo
et al.:
Low concordance between T-cell densities in matched primary tumors and liver metastases in microsatellite stable colorectal cancer
Frontiers in Oncology 2020
Sophie Sarah Steinhaeuser,
Erika Morera,
Zuzana Budkova,
Alexander Schepsky,
Qiong Wang,
Ottar Rolfsson
et al.:
ECM1 secreted by HER2-overexpressing breast cancer cells promotes formation of a vascular niche accelerating cancer cell migration and invasion
Laboratory Investigation 2020 DOI
Pierre Dillard,
Hakan Köksal,
Solrun Melkorka Maggadottir,
Anna Katharina Winge-Main,
Sylvie Mireille Pollmann,
Mathilde Ménard
et al.:
Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy
Molecular Therapy 2020 DOI
Ann Rita Halvorsen,
Mads Haugland Haugen,
Åsa Kristina Øjlert,
Marius Lund-Iversen,
Lars Hilmar Jørgensen,
Steinar Solberg
et al.:
Protein kinase C isozymes associated with relapse free survival in non-small cell lung cancer patients
Maria Lyngaas Torgersen,
Peter J. Judge,
Juan F. Bada Juarez,
Abhilash D. Pandya,
Markus Fusser,
Charlie W. Davies
et al.:
Physicochemical characterization, toxicity and in vivo biodistribution studies of a discoidal, lipid-based drug delivery vehicle: Lipodisq nanoparticles containing doxorubicin
Anna Barkovskaya,
Kotryna Seip,
Bylgja Hilmarsdòttir,
Gunhild Mari Mælandsmo,
Siver Andreas Moestue,
Harri Itkonen
:
O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes
Ketil Andre Camilio,
Mengyu Wang,
Brynjar Mauseth,
Stein Waagene,
Gunnar Kvalheim,
Øystein Rekdal
et al.:
Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model
Karine Flem-Karlsen,
Christina Tekle,
Tove Ragnhild Øyjord,
Vivi Ann Flørenes,
Gunhild Mari Mælandsmo,
Øystein Fodstad
et al.:
p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance
Caroline Elisabeth Nunes-Xavier,
Maite Emaldi,
Janire Mingo,
Tove Ragnhild Øyjord,
Gunhild Mari Mælandsmo,
Øystein Fodstad
et al.:
Author Correction: The expression pattern of pyruvate dehydrogenase kinases predicts prognosis and correlates with immune exhaustion in clear cell renal cell carcinoma (Scientific Reports, (2023), 13, 1, (7339), 10.1038/s41598-023-34087-x)
Scientific Reports 2023 DOI
Markus Fusser,
Anders Øverbye,
Abhilash D. Pandya,
Ýrr Asbjørg Mørch,
Sven Even F. Borgos,
Wanja Kildal
et al.:
Corrigendum to “Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft”, [Journal of Control Release, 293 (2019) 183–192, (Journal of Control Release, (2019) 293(183-192) (S0168365918306928), (10.1016/j.jconrel.2018.11.029))
Journal of Controlled Release 2022 DOI
The 50 latest publications is shown on this page. See all publications in Cristin here →